News

An inexpensive program using trained community members to deliver a structured program based on cognitive behavioral therapy by telephone was able to improve daily functioning, self-reported physical activity, and overall quality of life among diabetic patients with chronic pain, according to a clinical trial led by investigators at Weill Cornell Medicine, the University of Wisconsin-Madison and the University of Alabama at Birmingham.

The study, reported Jan. 13 in Annals of Family...

Weill Cornell Medicine scientists have built the first global database of clinical trials testing a rapidly expanding approach to cancer treatment that involves genetically modifying immune cells to recognize specific targets on a patient’s cancer cells and attack them. By analyzing the approach, called chimeric antigen receptor (CAR) therapies, the scientists designed a “therapeutic roadmap” that identifies all current therapies as well as additional cancers that can be treated with them....

A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a frequent cause of cancer deaths.

In their study, published Nov. 4 in Nature Cell Biology, the scientists found that CEMIP prompts blood vessel and resident immune cells in the...

Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, opened the first-ever National Conference on Medical Student Mental Health and Well-Being with a call to action.

“Arguably, medicine is the most noble profession, and we have to intervene so we’re not placing so much stress on our students and preventing them from becoming the best doctors they can be,” said Dr. Choi, as he stood in front of an audience of more than 350 medical school educators,...